Venus Remedies has bagged patent for Potentox drug from South African patent controller. This is the company’s third product patent in South Africa this year. Companies Intellectual Property Registration Office, South Africa, has granted the company patent of two more drugs – Sulbactomax and Tobracef.
Potentox is a super speciality product with combination of Cephalosporin with Aminoglycoside used in treatment of hospital acquired pneumonia, community acquired pneumonia and Febrile Neutropenia.
In a statement to national Stock Exchange, the company said that World Health Organisation suggest that there are 4.5 million cases of pneumonia each year and it causes 3.9 million deaths. In the sub-Saharan region of Africa 1.02 million people die. It was also the third leading cause of death in South Africa.
The company claimed that this drug can reduce treatment time for pneumonia from 21-20 day to 7-10 days.
After the announcement of the patent acquisition, the company’s shares surged 3.44 per cent. It was trading at Rs 224 during the market hours.
